Truist Financial Issues Positive Forecast for UnitedHealth Group (NYSE:UNH) Stock Price

UnitedHealth Group (NYSE:UNH - Free Report) had its price target increased by Truist Financial from $610.00 to $660.00 in a research report report published on Friday,Benzinga reports. Truist Financial currently has a buy rating on the healthcare conglomerate's stock.

Several other analysts have also recently issued reports on UNH. Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Hsbc Global Res upgraded shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Piper Sandler reduced their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a report on Thursday, January 2nd. Finally, Wells Fargo & Company cut their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 28th. Twenty-one equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $632.85.

Remove Ads

UnitedHealth Group Trading Down 2.2 %

Shares of NYSE:UNH traded down $13.24 during mid-day trading on Friday, reaching $586.23. 4,789,655 shares of the company were exchanged, compared to its average volume of 4,346,440. The firm has a market cap of $536.23 billion, a price-to-earnings ratio of 37.82, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group has a 1 year low of $438.50 and a 1 year high of $630.73. The firm's 50-day simple moving average is $512.87 and its 200 day simple moving average is $541.80.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group's revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.83 EPS. Equities research analysts forecast that UnitedHealth Group will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.43%. UnitedHealth Group's payout ratio is 54.19%.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is currently owned by insiders.

Institutional Investors Weigh In On UnitedHealth Group

Institutional investors have recently modified their holdings of the company. Northstar Advisory Group LLC purchased a new stake in UnitedHealth Group during the first quarter worth $1,273,000. Pallas Capital Advisors LLC grew its stake in UnitedHealth Group by 17.0% in the 1st quarter. Pallas Capital Advisors LLC now owns 23,471 shares of the healthcare conglomerate's stock valued at $12,293,000 after acquiring an additional 3,402 shares during the last quarter. WFA Asset Management Corp lifted its holdings in shares of UnitedHealth Group by 41.7% in the first quarter. WFA Asset Management Corp now owns 265 shares of the healthcare conglomerate's stock valued at $131,000 after purchasing an additional 78 shares in the last quarter. Cetera Trust Company N.A increased its stake in shares of UnitedHealth Group by 1.8% during the 1st quarter. Cetera Trust Company N.A now owns 5,515 shares of the healthcare conglomerate's stock worth $2,888,000 after purchasing an additional 100 shares in the last quarter. Finally, Farther Finance Advisors LLC lifted its stake in UnitedHealth Group by 23.9% in the 1st quarter. Farther Finance Advisors LLC now owns 15,614 shares of the healthcare conglomerate's stock valued at $8,168,000 after buying an additional 3,016 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.